![](/img/cover-not-exists.png)
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
Ruggiu, Mathilde, Oberkampf, Florence, Ghez, David, Cony-Makhoul, Pascale, Beckeriche, Florence, Cano, Isabelle, Taksin, Anne L., Benbrahim, Omar, Ghez, Stéphanie, Farhat, Hassan, Rigaudeau, Sophie, dLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2017.1397666
Date:
November, 2017
File:
PDF, 959 KB
english, 2017